IL97405A - Heterocyclic compounds, their preparation and pharmaceutical compositions containing them - Google Patents

Heterocyclic compounds, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL97405A
IL97405A IL9740591A IL9740591A IL97405A IL 97405 A IL97405 A IL 97405A IL 9740591 A IL9740591 A IL 9740591A IL 9740591 A IL9740591 A IL 9740591A IL 97405 A IL97405 A IL 97405A
Authority
IL
Israel
Prior art keywords
compound
formula
hydrogen
mmol
nmr
Prior art date
Application number
IL9740591A
Other languages
English (en)
Other versions
IL97405A0 (en
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL97405A0 publication Critical patent/IL97405A0/xx
Publication of IL97405A publication Critical patent/IL97405A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL9740591A 1990-03-16 1991-03-04 Heterocyclic compounds, their preparation and pharmaceutical compositions containing them IL97405A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK069790A DK69790D0 (da) 1990-03-16 1990-03-16 Heterocykliske forbindelser, deres fremstilling af anvendelse

Publications (2)

Publication Number Publication Date
IL97405A0 IL97405A0 (en) 1992-06-21
IL97405A true IL97405A (en) 1995-12-08

Family

ID=8096500

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9740591A IL97405A (en) 1990-03-16 1991-03-04 Heterocyclic compounds, their preparation and pharmaceutical compositions containing them

Country Status (20)

Country Link
US (1) US5166155A (da)
EP (1) EP0520024B1 (da)
JP (1) JPH05505810A (da)
AT (1) ATE139530T1 (da)
AU (1) AU652560B2 (da)
CA (1) CA2078429A1 (da)
CS (1) CS68791A3 (da)
DE (1) DE69120400T2 (da)
DK (2) DK69790D0 (da)
ES (1) ES2089204T3 (da)
FI (1) FI924118A7 (da)
GR (1) GR3020560T3 (da)
HU (1) HUT62274A (da)
IE (1) IE910685A1 (da)
IL (1) IL97405A (da)
NO (1) NO179949C (da)
NZ (1) NZ237431A (da)
PT (1) PT97047B (da)
WO (1) WO1991013878A1 (da)
ZA (1) ZA911779B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT101004B (pt) * 1991-10-26 1999-10-29 Schering Ag Derivados da quinoxalina, processo para a sua preparacao e composicoes farmaceuticas que os contem
US6057304A (en) * 1992-10-26 2000-05-02 Schering Aktiengesellschaft Quinoxaline-phosphonic acid derivatives
PT647137E (pt) * 1992-06-22 2008-11-24 Univ California Antagonistas dos receptores da glicina e a sua utilização
FR2696466B1 (fr) * 1992-10-02 1994-11-25 Rhone Poulenc Rorer Sa Dérivés de 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant.
IL109397A0 (en) * 1993-04-28 1994-07-31 Schering Ag Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DE4314592A1 (de) * 1993-04-28 1994-11-03 Schering Ag Benzo(f)chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
US5631373A (en) * 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
DE4340045A1 (de) * 1993-11-24 1995-06-01 Basf Ag Neue Chinoxaline und Arzneimittel daraus
IL112235A (en) * 1994-01-03 2000-06-29 Acea Pharm Inc 1,4-dihydro-pyrido¬2,3-b¾pyrazine-2,3-dione (5 or 8) oxide derivatives and pharmaceutical compositions containing them
DE4428152A1 (de) * 1994-06-22 1996-01-04 Basf Ag Neue Amido-chinoxalindione, ihrer Herstellung und Verwendung
DE4436852A1 (de) * 1994-10-14 1996-04-18 Basf Ag Pyrrolyl-tetrahydrobenzochinoxalindione, ihre Herstellung und Verwendung
DE4439492A1 (de) * 1994-10-25 1996-05-02 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
US5559447A (en) * 1994-11-17 1996-09-24 Cypress Semiconductor Output buffer with variable output impedance
DE19519979A1 (de) * 1995-05-24 1996-11-28 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE19521058A1 (de) * 1995-06-09 1996-12-12 Basf Ag Verfahren zur Herstellung von Aromaten enthaltenden Polyetherpolyolen
DE19545251A1 (de) * 1995-11-24 1997-05-28 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
GB9604400D0 (en) 1996-03-01 1996-05-01 Pfizer Ltd Compounds useful in therapy
DE19624808A1 (de) 1996-06-21 1998-01-02 Basf Ag Pyrrolylchinoxalindione, ihre Herstellung und Verwendung
ATE325128T1 (de) * 1996-10-24 2006-06-15 Novartis Pharma Gmbh Substituierte aminoalkanphosphonsäuren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
DK715888D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
DK716188D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse

Also Published As

Publication number Publication date
CS68791A3 (en) 1992-02-19
NZ237431A (en) 1993-09-27
CA2078429A1 (en) 1991-09-17
GR3020560T3 (en) 1996-10-31
AU7576791A (en) 1991-10-10
AU652560B2 (en) 1994-09-01
IE910685A1 (en) 1991-09-25
WO1991013878A1 (en) 1991-09-19
ES2089204T3 (es) 1996-10-01
EP0520024A1 (en) 1992-12-30
NO179949C (no) 1997-01-15
PT97047A (pt) 1991-10-31
HU9202953D0 (en) 1992-12-28
HUT62274A (en) 1993-04-28
FI924118A0 (fi) 1992-09-15
NO179949B (no) 1996-10-07
ATE139530T1 (de) 1996-07-15
NO923586D0 (no) 1992-09-15
PT97047B (pt) 1998-07-31
IL97405A0 (en) 1992-06-21
NO923586L (no) 1992-09-15
FI924118L (fi) 1992-09-15
EP0520024B1 (en) 1996-06-19
DK69790D0 (da) 1990-03-16
DE69120400D1 (de) 1996-07-25
ZA911779B (en) 1991-12-24
US5166155A (en) 1992-11-24
DE69120400T2 (de) 1996-12-19
DK0520024T3 (da) 1996-10-14
FI924118A7 (fi) 1992-09-15
JPH05505810A (ja) 1993-08-26

Similar Documents

Publication Publication Date Title
EP0520024B1 (en) Quinoxaline compounds and their preparation and use
US5081123A (en) Quinoxaline compound and their preparation and use
US4912108A (en) Pyridoquinoxaline compounds and their preparation and use as glutamate antagonists
AU626093B2 (en) Substituted quinoxaline-2,3(1h,4h)diones, their preparation and use
US5504085A (en) Triazolo quinoxalines and their preparation and use
US5532236A (en) [1,2,4]triazolo[4,3-a]quinoxaline compounds
US5182279A (en) Benzothienopyrazinedione compounds and their preparation and use
US5741785A (en) Heterocyclic compounds, their preparation and use
EP0511152A2 (en) Quinoxaline compounds, their preparation and use
US5308845A (en) Quinoxaline compounds and their preparation and use
US5153195A (en) Quinoxaline compounds and their preparation and use

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees